Maastricht University Medical Center
1,037
117
139
606
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
5.8%
60 terminated/withdrawn out of 1037 trials
91.0%
+4.5% vs industry average
9%
93 trials in Phase 3/4
2%
14 of 606 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (1037)
Acute Microbial Switch
Role: lead
Autologous Fat Grafting for Total Breast Reconstruction in Irradiated Breast Cancer Patients
Role: lead
Optimizing Access Surgery In Senior Hemodialysis Patients
Role: lead
Boosting Osimertinib Blood Brain Barrier Penetration
Role: lead
Glioblastoma Targeted Treatment Option Maximization by WGS
Role: collaborator
Clinical Study Evaluating Pharmacogenomics-informed Pharmacotherapy Versus Dosing as Usual in Psychiatric Disorders
Role: collaborator
Endobiliary Radiofrequency Ablation for Malignant Biliary Obstruction Due to Perihilar Cholangiocarcinoma
Role: collaborator
Clinical Impact of Using IMPROVE to Select Patients for Carotid Revascularisation
Role: lead
Developing Breast (Cancer) Organoids
Role: collaborator
Supplemental Screening for Women With Extremely Dense Breast Tissue: the DENSE-2 Trial
Role: collaborator
Restoring 24-hour Substrate Rhythmicity to Improve Glycemic Control by Timing of Lifestyle Factors
Role: collaborator
Improving Insulin Sensitivity in Patients With Type 2 Diabetes Via Repeated Cold-induced Shivering Thermogenesis
Role: collaborator
Weight Status, Resilience, and Quality of Life in Indian Children
Role: lead
Optimal Protein Intake to Maximize Whole-Body Protein Balance in Healthy Adults
Role: lead
The Effect of Pyridoxamine Supplementation on Microvascular Function in Type 2 Diabetes
Role: lead
Bleeding Disorder of Unknown Cause in the Netherlands
Role: lead
Digestion and Absorption Kinetics of Beef Consumed Alone or as Part of a Mixed-Meal: a Crossover Trial in Young Adults
Role: lead
Identification and Characterization of At-risk MASLD in Turkish Adults
Role: lead
Amino Acid Oxidation of Whole-Food Protein: a Dose-Response Crossover Trial in Young Adults
Role: lead
Tarlatamab for SCLC Brain Metastases
Role: lead